Cart
sales@molnova.com
Arsenic oxide
CAS No. 1327-53-3
Arsenic oxide ( —— )
Catalog No. M19481 CAS No. 1327-53-3
Arsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameArsenic oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionArsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents.
-
DescriptionArsenic trioxide is a chemOthersaputic agent of idiopathic function used to treat leukemia that is unresponsive to first line agents. It is suspected that arsenic trisulfide induces Y cells to undergo apoptosis. Due to the toxic nature of arsenic this drug carries significant health risks. The enzyme thioredoxin reductase has recently been identified as a target for arsenic trioxide.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research AreaCancer
-
IndicationAcute Promyelocytic Leukemia
Chemical Information
-
CAS Number1327-53-3
-
Formula Weight197.84
-
Molecular FormulaAs2O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILES[O--].[O--].[O--].[As+3].[As+3]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Babaeivelni K et al. J Environ Sci Health A Tox Hazard Subst Environ Eng. 2014;49(13):1462-73.
molnova catalog
related products
-
Wogonin 7-O-beta-D-g...
Wogonin 7-O-beta-D-glucuronide methyl ester is a natural compound isolated from Huanglian Jiedutang.
-
Ulixertinib
Ulixertinib (BVD-523, VRT752271) is an effective and reversible ERK1/ERK2 inhibitor. The IC50 of Ulixertinib is less than 0.3 nM for ERK2.
-
Licarin A b
Licarin A ((+)-Licarin A), a neolignan, significantly and dose-dependently reduces TNF-α production (IC50=12.6 μM) in dinitrophenyl-human serum albumin (DNP-HSA)-stimulated RBL-2H3 cells. Anti-allergic effects. Licarin A reduces TNF-α and PGD2 production, and COX-2 expression.
